MCM7 Antibodies

Santa Cruz Biotechnology delivers a wide array of MCM7 Antibodies for research in cell cycle regulation and DNA replication. MCM7 Antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MCM7, or Minichromosome Maintenance 7, plays a critical role in the initiation of DNA replication and is essential for maintaining genomic stability. As a component of the MCM complex, MCM7 is involved in the licensing of DNA replication origins, ensuring that DNA is accurately duplicated during the cell cycle. MCM7's dysregulation has been implicated in various cancers, making it a significant target for therapeutic research. Researchers worldwide rely on MCM7 monoclonal antibodies to advance their understanding of cell cycle regulation and DNA replication mechanisms. Validated data and consistent performance of MCM7 monoclonal antibodies enable precise detection and analysis in diverse experimental applications. MCM7 monoclonal antibodies from Santa Cruz Biotechnology empower researchers to make meaningful contributions to the scientific community's understanding of cellular processes and disease mechanisms.